THE PROGNOSTIC VALUE OF QUANTITATIVE ANGIOGENESIS IN BREAST-CANCER AND ROLE OF ADHESION MOLECULE EXPRESSION IN TUMOR ENDOTHELIUM

被引:59
|
作者
FOX, SB [1 ]
TURNER, GDH [1 ]
LEEK, RD [1 ]
WHITEHOUSE, RM [1 ]
GATTER, KC [1 ]
HARRIS, AL [1 ]
机构
[1] UNIV OXFORD,JOHN RADCLIFFE HOSP,ICRF MOLEC ONCOL,OXFORD OX3 9DU,ENGLAND
关键词
ADHESION MOLECULES; ANGIOGENESIS; IMMUNOHISTOCHEMISTRY; PROGNOSIS; SELECTINS; TUMOR VASCULARITY;
D O I
10.1007/BF00666042
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Angiogenesis is the formation of new capillaries from the existing vascular network and is essential for tumor growth and metastases. Increased microvessel density in breast cancer is associated with lymph node metastasis and reduced survival. We have assessed tumor vascularity in 211 breast carcinomas using a more rapid technique based on a Chalkley point eyepiece graticule. We confirmed using this method a significant reduction in overall survival between patients stratified by Chalkley count in both a univariate (p = 0.02) and multivariate (p = 0.05) analysis. Since studies have suggested that cell adhesion molecules (CAMs) might be important in the angiogenic process, and interaction of neoplastic cells with this neovasculature is a significant step in tumor metastasis, we have also examined the expression of CAMs in a subset of these tumors (n = 64). Using immunohistochemistry we observed widespread and intense staining on the endothelium of tumor-associated vessels for PECAM (100%), ICAM 1 (69%), and E- and P-selectins (52% and 59% of cases respectively). Endothelial expression of the selectins was more prominent at the tumor periphery. Immunoreactivity of ICAM-1 (34%), PECAM (1.6%), and E- and P-selectins (7% and 37% of cases respectively) was also observed on the neoplastic element of the tumors.
引用
收藏
页码:219 / 226
页数:8
相关论文
共 50 条
  • [31] SERIAL SCINTISCANNING IN BREAST-CANCER - THE INDICATIONS AND PROGNOSTIC VALUE
    FURNIVAL, CM
    BLUMGART, LH
    CITRIN, DL
    MCKILLOP, JH
    FOGELMAN, I
    GREIG, WR
    [J]. CLINICAL ONCOLOGY-US, 1980, 6 (01): : 25 - 32
  • [32] THE PROGNOSTIC VALUE OF ESTROGEN-RECEPTORS IN BREAST-CANCER
    MERCER, RJ
    BRYAN, RM
    BENNETT, RC
    RENNIE, GC
    LIE, TH
    MORGAN, FJ
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1984, 54 (01): : 7 - 10
  • [33] PROGNOSTIC VALUE OF PROLACTIN RECEPTORS IN HUMAN BREAST-CANCER
    BERRUTI, A
    FAGGIUOLO, R
    MASCHIETTO, M
    DICARLO, R
    MUCCIOLI, M
    DICARLO, F
    RENDINE, S
    DOGLIOTTI, L
    [J]. EUROPEAN JOURNAL OF CANCER, 1990, 26 (02) : 177 - 177
  • [34] PROGNOSTIC VALUE OF CARCINOEMBRYONIC ANTIGEN IN PATIENTS WITH BREAST-CANCER
    SMITH, JF
    [J]. SOUTHERN MEDICAL JOURNAL, 1977, 70 (06) : 722 - 724
  • [35] THE PROGNOSTIC VALUE OF MORPHOMETRICAL CELLULAR EXAMINATION IN BREAST-CANCER
    VANDIEST, PJ
    BAAK, JPA
    MOURIQUAND, J
    [J]. CONTRACEPTION FERTILITE SEXUALITE, 1991, 19 (06): : 519 - 522
  • [36] PROGNOSTIC VALUE OF ESTROGEN RECEPTORS IN PRIMARY BREAST-CANCER
    HAHNEL, R
    WOODINGS, T
    VIVIAN, AB
    [J]. CANCER, 1979, 44 (02) : 671 - 675
  • [37] PROGNOSTIC VALUE OF PROGESTERONE RECEPTORS IN PRIMARY BREAST-CANCER
    PICHON, MF
    PALLUD, C
    BRUNET, M
    MILGROM, E
    [J]. RECENT RESULTS IN CANCER RESEARCH, 1984, 91 : 186 - 191
  • [38] AGNOR COUNTS HAVE NO PROGNOSTIC VALUE IN BREAST-CANCER
    TOIKKANEN, S
    JOENSUU, H
    [J]. JOURNAL OF PATHOLOGY, 1993, 169 (02): : 251 - 254
  • [39] PROGNOSTIC VALUE OF TNM CATEGORY AND GRADE IN BREAST-CANCER
    IBANEZ, T
    BILBAO, J
    TOLEDO, JD
    [J]. PATHOLOGE, 1993, 14 (03): : 144 - 149
  • [40] PROGNOSTIC VALUE OF ESTROGEN AND PROGESTERONE RECEPTORS IN BREAST-CANCER
    SAEZ, S
    PICHON, MF
    [J]. SEMAINE DES HOPITAUX, 1984, 60 (12): : 852 - 859